Page last updated: 2024-12-11

turanose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

turanose : A glycosylfructose isolated from Daphnia magna. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5460935
CHEBI ID32528
SCHEMBL ID37172
MeSH IDM0093936

Synonyms (30)

Synonym
alpha-d-glucopyranosyl-(1->3)-d-fructose
CHEBI:32528
alpha-d-glcp-(1->3)-d-fru
3-o-alpha-d-glucopyranosyl-d-fructose
turanose
6DC826C6-9BDF-4B8B-AB8B-1E54ECA76A55
alpha-d-glucopyranose-(1->3)-beta-d-fructose
beta-turanose
OTU ,
C19636
turanose (van)
unii-6d600ary3r
6d600ary3r ,
d-fructose, 3-o-alpha-d-glucopyranosyl-
nsc 1222
einecs 208-918-5
d-(+)-turanose (van)
S9448
3-(.alpha.-d-glucosido)-d-fructose
turanose [mi]
turanose, d-
SCHEMBL37172
(3s,4r,5r)-1,4,5,6-tetrahydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexan-2-one
3-o-hexopyranosylhex-2-ulose
3-o-a-d-glucopyranosyl-d-fructose
(3s,4r,5r)-1,4,5,6-tetrahydroxy-3-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexan-2-one
3-o-alpha-d-glucosyl-d-fructose; 3-o-d-glucosyl-d-fructose; 3-o-glucosyl-d-fructose
HY-113334
CS-0059630
DTXSID90876998

Research Excerpts

Overview

Turanose is a sucrose isomer naturally existing in honey. It is a promising functional sweetener due to its low glycemic response.

ExcerptReferenceRelevance
"Turanose is a natural isomer of sucrose. "( Characterization of a novel amylosucrase gene from the metagenome of a thermal aquatic habitat, and its use in turanose production from sucrose biomass.
Agarwal, N; Narnoliya, LK; Singh, SP, 2019
)
2.17
"Turanose is a sucrose isomer naturally existing in honey and a promising functional sweetener due to its low glycemic response. "( Enzymatic Process for High-Yield Turanose Production and Its Potential Property as an Adipogenesis Regulator.
Kang, HK; Kim, Y; Lee, BH; Lee, HG; Lim, E; Lim, JY; Park, CS; Park, MO; Yoo, SH, 2016
)
2.16

Treatment

Turanose treatments at concentrations representing 50%, 75%, and 100% of total glucose concentration in cell media significantly reduced lipid accumulation. Turanose-treated seedlings are characterized by a very short primary root and a short hypocotyl showing the production of adventitious roots.

ExcerptReferenceRelevance
"Turanose treatments at concentrations representing 50%, 75%, and 100% of total glucose concentration in cell media significantly reduced lipid accumulation by 18%, 35%, and 72%, respectively, as compared to controls."( Enzymatic Process for High-Yield Turanose Production and Its Potential Property as an Adipogenesis Regulator.
Kang, HK; Kim, Y; Lee, BH; Lee, HG; Lim, E; Lim, JY; Park, CS; Park, MO; Yoo, SH, 2016
)
1.44
"Turanose-treated seedlings are characterized by a very short primary root and a short hypocotyl showing the production of adventitious roots."( A turanose-insensitive mutant suggests a role for WOX5 in auxin homeostasis in Arabidopsis thaliana.
Alpi, A; Gonzali, S; Loreti, E; Novi, G; Paolicchi, F; Perata, P; Poggi, A, 2005
)
1.77
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glycosylfructose
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.45)18.7374
1990's7 (22.58)18.2507
2000's10 (32.26)29.6817
2010's10 (32.26)24.3611
2020's2 (6.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.86 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index52.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]